Vach W - Search Results

1

Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis.

du Bois A, Vach W, Kiechle M, Cramer-Giraud U, Meerpohl HG. du Bois A, et al. Among authors: vach w. Oncology. 1996 Jun;53 Suppl 1:46-50. doi: 10.1159/000227640. Oncology. 1996. PMID: 8692551 Review.

2

Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron.

du Bois A, Meerpohl HG, Vach W, Kommoss FG, Fenzl E, Pfleiderer A. du Bois A, et al. Among authors: vach w. Eur J Cancer. 1992;28(2-3):450-7. doi: 10.1016/s0959-8049(05)80075-9. Eur J Cancer. 1992. PMID: 1534250

3

Comparison of the emetogenic potential between cisplatin and carboplatin in combination with alkylating agents.

du Bois A, Vach W, Thomssen C, Karck U, Madjar H, Prömpeler H, Meerpohl HG. du Bois A, et al. Among authors: vach w. Acta Oncol. 1994;33(5):531-5. doi: 10.3109/02841869409083931. Acta Oncol. 1994. PMID: 7917367 Clinical Trial.

4

Pattern of carboplatin-induced emesis. The German Ondansetron Study Group.

du Bois A, Vach W, Cramer-Giraud U, Thomssen C, Glaubitz M, Fiola M. du Bois A, et al. Among authors: vach w. Anticancer Drugs. 1995 Oct;6(5):645-51. doi: 10.1097/00001813-199510000-00003. Anticancer Drugs. 1995. PMID: 8845474 Clinical Trial.

5

5-Hydroxyindoleacetic acid (5-HIAA) and cortisol excretion as predictors of chemotherapy-induced emesis.

du Bois A, Vach W, Wechsel U, Holy R, Schaefer W. du Bois A, et al. Among authors: vach w. Br J Cancer. 1996 Oct;74(7):1137-40. doi: 10.1038/bjc.1996.503. Br J Cancer. 1996. PMID: 8855988 Free PMC article.

6

5-Hydroxyindoleacetic acid excretion following combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil plus ondansetron compared to ondansetron alone.

du Bois A, Vach W, Holy R, Kriesinger-Schröder H. du Bois A, et al. Among authors: vach w. Support Care Cancer. 1996 Sep;4(5):384-9. doi: 10.1007/BF01788846. Support Care Cancer. 1996. PMID: 8883233 Clinical Trial.

7

The relationship between parameters of serotonin metabolism and emetogenic potential of platinum-based chemotherapy regimens.

du Bois A, Vach W, Siebert C, Holy R, Ledergerber M, Wechsel U, Kriesinger-Schroeder H. du Bois A, et al. Among authors: vach w. Support Care Cancer. 1997 May;5(3):212-8. doi: 10.1007/s005200050062. Support Care Cancer. 1997. PMID: 9176967

8

Cisplatin-induced alterations of serotonin metabolism in patients with or without emesis following chemotherapy.

Dubois A, Siebert C, Vach W, Kriesingerschroeder H. Dubois A, et al. Among authors: vach w. Oncol Rep. 1995 Sep;2(5):839-42. doi: 10.3892/or.2.5.839. Oncol Rep. 1995. PMID: 21597827

9

[Effect of pregnancy on the incidence and course of malignant diseases].

du Bois A, Meerpohl HG, Gerner K, Prömpeler H, Vach W, Aisslinger U, Breckwoldt M, Pfleiderer A. du Bois A, et al. Among authors: vach w. Geburtshilfe Frauenheilkd. 1993 Sep;53(9):619-24. doi: 10.1055/s-2007-1023598. Geburtshilfe Frauenheilkd. 1993. PMID: 8224722 German.

10

[Effect of pregnancy and labor on serotonin metabolism].

du Bois A, Schäfer CA, Vach W, Prömpeler H, Bauknecht T, Breckwoldt M. du Bois A, et al. Among authors: vach w. Geburtshilfe Frauenheilkd. 1995 Sep;55(9):500-4. doi: 10.1055/s-2007-1022828. Geburtshilfe Frauenheilkd. 1995. PMID: 7498717 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page